Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Shenghuo Pharmaceutical has reported sales of $10.5m for the fourth quarter ended December 31, 2009, an increase of 43.8%, compared to $7.3m for the same period in 2008.
Subscribe to our email newsletter
China Shenghuo has posted a net income attributable to stockholders for the fourth quarter 2009 of $0.2m, compared with a net loss of $2.4m for the fourth quarter 2008. Basic and diluted earnings per share were $0.01 for the fourth quarter 2009, compared to $0.12 for the prior year period.
For the year ended December 31, 2009, the company has posted sales of $36m, an increase of 25.5%, compared to $28.7m for the year ago period. Net loss attributable to stockholders was $6.6m, or $0.33 loss per fully basic and diluted share, compared to $4.6m, or $0.24 loss per fully basic and diluted share, for the year ago period.
Gui Hua Lan, CEO of China Shenghuo, said: “The increase in sales was primarily due to the Company’s implementation of a new sales policy that has stimulated the enthusiasm of sales representatives, resulting in the increased sales of products. Our primary products, Xuesaitong Soft Capsules and the innovative 12 Ways cosmetic products continued to produce meaningful growth in a difficult market environment.”
China Shenghuo Pharmaceutical is a specialty pharmaceutical company that focuses on the manufacture, research, development and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products.